Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 September 2021 | Story Nonsindiso Qwabe | Photo Supplied
Dr Samantha Potgieter.

As COVID-19 vaccines continue to be a topical issue in South Africa and indeed in the world itself, the Department of Human Resources held a webinar for the UFS community on 10 September that delved deeper into the questions surrounding the vaccine. 

Dr Samantha Potgieter, infectious disease expert at the Universitas Academic Hospital and affiliated Lecturer in the Department of Internal Medicine at the University of the Free State, addressed some commonly raised concerns about the COVID-19 vaccine and how it affects us.

Dr Potgieter started off by saying that coronaviruses have been causing outbreaks among humans for millennia. While COVID-19 is relatively mild and self-limiting in 80% of patients, 20% of patients are at risk of developing severe disease.
She said before a vaccine could be introduced to a population, it had to go through rigorous testing and clinical trials. Only once safety has been confirmed, it can be released and distributed. 

“This process usually takes about ten years; this is what we are used to. But it has happened much quicker for the COVID-19 vaccine, and I think this is a fact that many people misinterpret – that the evidence might not be that robust, which is certainly not the case. COVID-19 vaccines have gone through all this rigorous testing, thousands of patients had volunteered for trial testing studies. The point is that we already had the technology, vaccination is not something new to humans. So, these preclinical trials were able to happen very quickly, and because of the large number of infections and because the focus of the entire world was on finding a cure, it was a very set process to get these trials through the adequate phases.” 

She said the COVID-19 vaccine was approved by national regulators, manufactured to exacting standards, and only thereafter distributed – as is the case for all drugs released into the market.

How does the vaccine work?

Dr Potgieter said the vaccine works by producing antibodies against the COVID-19 virus. If you are infected with the COVID-19 virus after getting vaccinated, these antibodies bind to the virus and stop it from replicating.

“When you get infected with a disease such as COVID-19, natural antibodies are produced by the immune system to fight the disease. If you get infected again, the immune system will remember how to respond, and quickly destroy the virus. A vaccine can do the same, but without the risk of disease from natural infection. Vaccines work by imitating a bacteria or virus using either mRNA in the case of the COVID-19 vaccine, or a dead or weakened version of the bacteria or virus. The vaccine raises the body’s alarm. It trains the body to recognise and fight the virus. When the body encounters the real-deal virus, it is primed and ready to fight for the body’s health.”

She said South Africa had the mRNA vaccine in the form of the Pfizer vaccine, and the adenoviral vector vaccine in the form of the Johnson & Johnson vaccine.

Why should you get the vaccine?

Dr Potgieter said vaccines are safe and effective, and the most compelling reasons for getting vaccinated are the following:

-To protect yourself from severe disease
-To protect those around you who may be at risk of severe disease
-To restore the social and economic platforms of the country, and the world at large.
She said that while the vaccine does not prevent you from getting COVID-19, it offers better protection against the development of severe disease, and vaccinated people had 50% less chance of spreading the virus.
The most common side effects of the vaccine are the following:
-Pain at the injection site
-Swollen lymph nodes
-Fever
-Fatigue
-Headache
-Myalgia (muscle pain)

“These are indications that the immune system is mounting a response. When it mounts a response, it produces antibodies,” she said.

Answers to commonly asked questions are the following:

1. Can the vaccine alter my DNA?
“No, it goes nowhere near the nucleus of the cell.”

2. What happens when you get COVID in between the first and second doses?
“Some protection is conferred after the first dose, but maximum protection is conferred two weeks after the second dose. Vaccination is still advised.” 

Dr Potgieter said patients who were between vaccinations still show better recovery results than those without.

3. What about natural immunity?
“Natural immunity might confer better protection, but it runs the risk of severe disease. Yes, immunity can be gained through natural immunity, it can be gained through vaccination, and it can certainly be gained by a combination of the two.”

4. What about long-term side effects?
“Serious side effects that cause long-term health problems following any vaccination are very rare, including the COVID-19 vaccination.”

To get the answers to more of your questions, the webinar can be accessed via the following link: https://event.webinarjam.com/go/replay/43/053q6a8vay9a0qa2

News Archive

UFS to host one the most prestigious seminars in leadership
2004-09-28

The Business School of the University of the Free State (UFS) will be hosting the Central Region’s screening of the largest global satellite broadcast of the 2004 Living Leadership: Delivering Results the Right Way event.

The event, which will take place on 21 October 2004 from 09:00-16:30 at the Albert Wessels Auditorium on campus, will be up linked from Atlanta, Georgia, USA, and will be broadcasted via satellite to 95 cities in two countries.

“This is a once in a lifetime opportunity for leaders in the Central Region to gain exposure to the pioneers in the international leadership field,” said Prof Helena van Zyl, Director of the UFS’s School of Management.

The global satellite simulcast will bring together a powerful diverse group of the world’s leading business authorities. This includes Mr Donald Trump, chairman of The Trump Organisation; Mr Mikhail Gorbachev, Nobel Peace Prize Winner and former president of the Soviet Union; Mr Jim Collins, speaking on his recent best-seller, Good To Great; Mr Peter Drucker, father of management and author of The Effective Executive; Ms Rosabeth Moss Kanter, professor at Harvard Business School; Mr Ken Blanchard, best-selling author of The One Minute Manager; Mr John C Maxwell, best-selling author of The 21 Irrefutable Laws of Leadership and acclaimed speaker; Mr Russell Simmons, entrepreneur and co-founder of Def Jam Records and Mr Larry Bossidy, co-author of the best-seller, Execution: The Discipline of Getting Things Done.

According to Prof Van Zyl the Living Leadership global satellite broadcast will give attendants exclusive access to the Financial Mail’s Executive Panel. It will also give local executives and renowned leaders the opportunity to share their interpretation of leadership in practical, relevant terms.

Mr Jack Welch’s executive assistant and author of Managing Up, Ms Rosanne Badowski and Ms Caroline Kepcher, an executive vice president to Mr Donald Trump and a lead role on NBC’s hit show, The Apprentice, will join the panel with a special session.

Each of the cutting-edge insights shared by this gathering of world-class leadership authorities will deliver effective benchmarks which teams will use to shape their business outcomes.

The cost is R950,00 per person (group discount is also available) – this includes the receipt of two free issues of the Financial Mail. Tickets are available at Computicket.

For more information on this seminar visit www.livingleadership.co.za or contact Ms Isa Boshoff at 051-4012874 / boshofia.ekw@mail.uovs.ac.za .

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
28 September 2004
 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept